NASDAQ:CLDX

Celldex Therapeutics Stock Forecast

etoro logo Buy CLDX
*Your capital is at risk
$26.00
+0.450 (+1.76%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of CLDX
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Stronger technical forecast for Celldex Therapeutics stock price after Monday trading
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Nov 17, 2025

The Celldex Therapeutics stock price gained 1.76% on the last trading day (Monday, 17th Nov 2025), rising from $25.55 to $26.00. During the last trading day the stock fluctuated 4.11% from a day low at $25.46 to a day high of $26.50. The price has fallen in 7 of the last 10 days but is still up by 5.05% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 183 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $29.14 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 11.69% during the next 3 months and, with a 90% probability hold a price between $25.58 and $32.17 at the end of this 3-month period.

CLDX Signals & Forecast

The Celldex Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $24.21 and $25.87. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, November 10, 2025, and so far it has risen 14.69%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Celldex Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $24.61 and $22.02. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Celldex Therapeutics finds support just below today's level at $24.61. If this is broken, then the next support from accumulated volume will be at $22.02 and $20.89.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.05 between high and low, or 4.11%. For the last week, the stock has had daily average volatility of 7.02%.

Our recommended stop-loss: $24.93 (-4.10%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 5 days ago.)

Trading Expectations (CLDX) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Celldex Therapeutics to open at $25.99, and during the day (based on 14 day Average True Range), to move between $25.37 and $26.63, which gives a possible trading interval of +/-$1.26 (+/-4.97%) up or down from last closing price. If Celldex Therapeutics takes out the full calculated possible swing range there will be an estimated 4.97% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $26.72 (2.77%) than the support at $24.61 (5.35%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Celldex Therapeutics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Celldex Therapeutics stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 2.087 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $25.99 ( 0.0577%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

CLDX Performance

Trading levels for CLDX

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 27.03 3.96%
R2 26.63 2.43%
R1 26.38 1.48%
Price 26.00
S1 25.59 -1.59%
S2 25.34 -2.54%
S3 24.94 -4.08%

Accumulated Volume Support & Resistance Levels

Level Price
R3 26.77 2.96%
R2 26.73 2.81%
R1 26.72 2.77%
Price 26.00
S1 24.61 -5.35%
S2 22.02 -15.31%
S3 20.89 -19.65%

FAQ

What is the symbol for Celldex Therapeutics Stock and on which exchange is it traded?
The symbol for Celldex Therapeutics is CLDX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Celldex Therapeutics Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Celldex Therapeutics stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy Celldex Therapeutics Stock?
Celldex Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Celldex Therapeutics Stock.

What's the current price of Celldex Therapeutics Stock?
As of the end of day on the Nov 17, 2025, the price of an Celldex Therapeutics (CLDX) share was $26.00.

What is the 52-week high and low for Celldex Therapeutics Stock?
The 52-week high for Celldex Therapeutics Stock is $29.05 and the 52-week low is $14.40.

What is the market capitalization of Celldex Therapeutics Stock?
As of the Nov 17, 2025, the market capitalization of Celldex Therapeutics is 1.576B.

When is the next earnings date for Celldex Therapeutics?
The upcoming earnings date for Celldex Therapeutics is Feb 26, 2026.
Click to get the best stock tips daily for free!
ABOUT CELLDEX THERAPEUTICS
Celldex Therapeutics
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE